Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185211
Status:
COMPLETED
Last Update Posted:
2013-12-30
First Post:
2005-09-09
Brief Title:
BENEFIT Study Betaferon Betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment and BENEFIT Follow-up Study
Sponsor:
Bayer
Organization:
Bayer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Multiple Sclerosis |
Keywords: